MetLife Investment Management’s Genomic Health, Inc. GHDX Stock Holding History

MetLife Investment Management’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-12,302	Closed	-$834K	–	2373
2019 Q3	$834K	Hold	12,302	–	–	0.01%	1160
2019 Q2	$716K	Buy	12,302 +3,468	+39%	+$205K	0.01%	1279
2019 Q1	$619K	Hold	8,834	–	–	0.01%	1332
2018 Q4	$569K	Hold	8,834	–	–	0.01%	1285
2018 Q3	$620K	Sell	8,834 -2,155	-20%	-$126K	0.01%	1395
2018 Q2	$554K	Buy	10,989 +2,179	+25%	+$86.5K	0.01%	1354
2018 Q1	$276K	Hold	8,810	–	–	﹤0.01%	1726
2017 Q4	$301K	Buy	+8,810	New	+$281K	﹤0.01%	1710

MetLife Investment Management's GHDX Position: Q4 2019 in Review

MetLife Investment Management sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 12,302 shares — an estimated $834K sold.

MetLife Investment Management first reported a position in GHDX in Q4 2017 and held it in 8 quarters. The position peaked at $834K in Q3 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

MetLife Investment Management reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
MetLife Investment Management sold 12,302 Genomic Health, Inc. shares in Q4 2019, an estimated $834K.
MetLife Investment Management first reported a position in Genomic Health, Inc. in Q4 2017 and held it in 8 quarters.
MetLife Investment Management's Genomic Health, Inc. position peaked at $834K in Q3 2019.
0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on MetLife Investment Management's 13F filing for Q4 2019, filed 14 Feb 2020.